SEC Form 4/A · accession 0001140361-16-078549
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Willard H Dere
Director
Period of report
Jul 15, 2016
Accepted (ET)
Sep 1, 2016 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 15, 2016 | A | 2,640 | $0.00 | A | 2,640 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1,F3 | $92.08 | Jul 15, 2016 | A | 9,880 | A | Jul 15, 2017 | Jul 14, 2026 | Common Stock | 9,880 | 9,880 | D |
Explanation of responses
- F1This amendment is being filed solely to correct an administrative error in the original filing regarding the number of stock options and restricted stock units reported as granted.
- F2Restricted stock units granted on July 15, 2016 vest annually over three years. Price not applicable.
- F3Original option grant vests annually over three years